American Psychopathological Association

American Psychopathological Association
Name	American Psychopathological Association
Formation	1910
Headquarters	United States
Type	Learned society
Fields	Psychopathology
Leader title	President

Contents

American Psychopathological Association is a learned society founded in 1910 that promotes research into mental disorders, psychopathology, and related neuroscientific and clinical studies. The association convenes clinicians, researchers, and scholars from institutions such as Columbia University, Johns Hopkins University, Massachusetts General Hospital, Harvard University, and Yale University to present findings and advance nosology. Its meetings and publications have intersected with work at organizations including National Institute of Mental Health, American Psychiatric Association, World Health Organization, National Academies of Sciences, Engineering, and Medicine, and Wellcome Trust.

History

The association was established in 1910 amid contemporaneous developments at Rockefeller Institute for Medical Research, Clark University, University of Pennsylvania, Cornell University, and University of Chicago where investigators such as figures associated with Sigmund Freud, Emil Kraepelin, Eugen Bleuler, Ernest Jones, and Karl Menninger influenced early psychopathology debates. In mid‑20th century periods the association's activities intersected with initiatives at Institute for Advanced Study, Monroe Laboratory, Brookhaven National Laboratory, and federal programs tied to National Institutes of Health. During the 1950s–1970s the association engaged scholars connected to Aaron Beck, B.F. Skinner, Carl Rogers, Melvin R. Novick, and John Bowlby, while later decades saw participation from investigators affiliated with Stanford University, University of California, Los Angeles, King's College London, University College London, and Cambridge University.

The association's mission emphasizes stimulation of research into psychopathological processes, fostering dialogue among clinicians and scientists linked to American College of Neuropsychopharmacology, Society for Neuroscience, Association for Psychological Science, International Society for Research in Psychopathology, and academic departments at Princeton University and University of Pennsylvania. Objectives include promoting empirical studies related to classification systems such as those from Diagnostic and Statistical Manual of Mental Disorders and International Classification of Diseases, facilitating interdisciplinary linkages with investigators at Max Planck Institute for Psychiatry, Salk Institute, Cold Spring Harbor Laboratory, and supporting translation to practice in settings associated with Beth Israel Deaconess Medical Center and Mount Sinai Hospital.

Membership historically comprises researchers, clinicians, and educators elected from universities and hospitals including University of Michigan, Columbia-Presbyterian Medical Center, Duke University, Northwestern University, Vanderbilt University Medical Center, UCSF School of Medicine, and international centers at Karolinska Institute, Université Paris Cité, University of Toronto, and Monash University. Governance typically features an executive committee, officers, and sectional chairs drawn from such institutions, with presidents who have had academic links to Yale School of Medicine, Harvard Medical School, Johns Hopkins School of Medicine, and research programs at NIH Clinical Center. Committees coordinate activities with entities like American Psychological Association divisions and advisory bodies connected to Samueli Academy and professional boards.

Annual meetings bring presenters from programs at Columbia University Vagelos College of Physicians and Surgeons, Beth Israel Deaconess, Mount Sinai School of Medicine, Mayo Clinic, Cleveland Clinic, and international centers like European College of Neuropsychopharmacology affiliates. Symposia and workshops have featured keynote contributors affiliated with National Institute on Drug Abuse, National Institute of Mental Health, Karolinska Institutet, University of Oxford, Imperial College London, and philanthropic supporters such as Bill & Melinda Gates Foundation and Michael J. Fox Foundation. Sessions cover intersections with research from laboratories associated with Cold Spring Harbor Laboratory, Salk Institute for Biological Studies, Broad Institute, Allen Institute for Brain Science, and collaborations with specialty societies including Society for Biological Psychiatry.

The association sponsors awards and lectures honoring investigators aligned with traditions at American Psychiatric Association and memorials connected to figures from Columbia University and Johns Hopkins University. Prize recipients often come from programs at Stanford University School of Medicine, Harvard Medical School, Yale School of Medicine, University of California, San Diego, and international research centers such as Max Planck Society and Institut National de la Santé et de la Recherche Médicale. Publications and proceedings have been disseminated through journals and outlets associated with American Journal of Psychiatry, Biological Psychiatry, Journal of Abnormal Psychology, Psychological Medicine, and edited volumes connected to university presses at Oxford University Press, Cambridge University Press, and MIT Press.

Research promoted by the association has influenced etiologic models and treatment paradigms advanced by investigators at National Institute of Mental Health, Mount Sinai Health System, Massachusetts General Hospital, UCLA Neuropsychiatric Institute, and international collaborators at Karolinska Institutet, University of Oxford, and McGill University. Work presented at association meetings has intersected with seminal studies on neurotransmission associated with Paul Greengard, neuroimaging studies linked to Karl Friston, cognitive therapy developments associated with Aaron Beck, and developmental psychopathology research tied to John Bowlby and Mary Ainsworth. The association's emphasis on translational, neurobiological, and longitudinal approaches has affected practice and policy discussions at bodies such as World Health Organization, National Academies of Sciences, Engineering, and Medicine, and regulatory agencies like Food and Drug Administration.

Category:Psychiatry organizations